This inventor holds 3 USPTO granted patents and 2 published patent applications. Top assignee: Carisma Therapeutics Inc.. Active years: 2022-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2026
Title: Innovations by Nicholas R Anderson in Immunotherapy
Introduction
Nicholas R Anderson is a prominent inventor based in Philadelphia, PA (US), known for his significant contributions to the field of immunotherapy. With a total of 3 patents, he has made strides in enhancing the efficacy of immune cells in targeting tumors.
Latest Patents
His latest patents include a method of increasing tumor-killing activity of macrophages or monocytes comprising chimeric antigen receptors (CARs). This patent focuses on immune cells that utilize CARs and outlines methods for their application. Another notable patent is related to constructs for chimeric antigen receptors, which also emphasizes the use of immune cells equipped with CARs.
Career Highlights
Nicholas R Anderson is currently associated with Carisma Therapeutics Inc., a company dedicated to advancing CAR technology in cancer treatment. His work is pivotal in developing innovative therapies that harness the power of the immune system to combat cancer.
Collaborations
He collaborates with notable colleagues such as Michael Klichinsky and Nicholas G Minutolo, contributing to a dynamic research environment focused on groundbreaking advancements in immunotherapy.
Conclusion
Nicholas R Anderson's work exemplifies the intersection of innovation and healthcare, particularly in the realm of cancer treatment through immunotherapy. His patents and collaborations reflect a commitment to improving patient outcomes and advancing scientific knowledge.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile